Postnatal haloperidol eliminates the deficit in circling behavior produced by prenatal exposure to the same drug

Up to 35% of pregnant women take psychotropic drugs at least once during gestation [Austin and Mitchell, 1998]. From concurrent animal and human evidence, it has been proposed that exposure to several psychoactive medications in utero or during lactation increases the risk for permanent brain disord...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Wolansky, M.J
Otros Autores: Soiza-Reilly, M., Fossati, M., Azcurra, J.M
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: 2004
Acceso en línea:Registro en Scopus
DOI
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 19578caa a22016937a 4500
001 PAPER-21217
003 AR-BaUEN
005 20230518205239.0
008 190411s2004 xx ||||fo|||| 00| 0 eng|d
024 7 |2 scopus  |a 2-s2.0-2942625682 
024 7 |2 cas  |a haloperidol, 52-86-8; Dopamine Antagonists; Haloperidol, 52-86-8; Spiperone, 749-02-0; Tritium, 10028-17-8 
040 |a Scopus  |b spa  |c AR-BaUEN  |d AR-BaUEN 
030 |a NETEE 
100 1 |a Wolansky, M.J. 
245 1 0 |a Postnatal haloperidol eliminates the deficit in circling behavior produced by prenatal exposure to the same drug 
260 |c 2004 
270 1 0 |m Azcurra, J.M.C. F. Melo 4127 (C.P. 1602), Buenos Aires, Argentina; email: azcuipon@bg.fcen.uba.ar 
506 |2 openaire  |e Política editorial 
504 |a Andersen, S.L., Gazzara, R.A., Effects of (-)-sulpiride on dopamine release in striatum of developing rats: Degree of depolarization influences responsiveness (1996) J. Neurochem., 67 (5), pp. 1931-1937 
504 |a Austin, M.-P.V., Mitchell, P.B., Psychotropic medications in pregnant women: Treatment dilemmas (1998) Med. J. Aust. (Australia), 169, pp. 428-431 
504 |a Baldessarini, R.J., Tarazi, F.I., Drugs and the treatment of psychiatric disorders: Psychosis and mania (2001) The Pharmacological Basis of Therapeutics Tenth Edition, pp. 485-519. , J.G. Hardman, L.E. Limbird, & A. Goodman Gilman. New York: MacGraw-Hill. Chapter 20 
504 |a Barik, S., Beaurepaire, R., Evidence for a functional role of the dopamine D3 receptors in the cerebellum (1996) Brain Res., 737 (12), pp. 347-350 
504 |a Brusés, J.L., Azcurra, J.M., The circling training: A behavioral paradigm for functional teratology testing (1993) Paradigms for the Study of Behavior Methods Neurosci., 14, pp. 166-179. , P.M. Conn. New York: Academic Press 
504 |a Brusés, J.L., Berninsone, P.M., Ojea, S., Azcurra, J.M., The circling training rat model as a behavioral teratology test (1991) Pharmacol. Biochem. Behav., 38, pp. 739-745 
504 |a Burger, J., Gochfield, M., Lead and neurobehavioral development in gulls: A model for understanding effects in the laboratory and the field (1997) Neurotoxicology, 18 (2), pp. 495-506 
504 |a Burke, R.E., Postnatal developmental programmed cell death in dopamine neurons (2003) Ann. N.Y. Acad. Sci., 991, pp. 69-79 
504 |a Cagiano, R., Barfield, R.J., White, N.R., Pleim, E.T., Weinstein, M., Cuomo, V., Subtle behavioral changes produced in rat pups by in utero exposure to haloperidol (1988) Eur. J. Pharmacol., 157 (1), pp. 45-50 
504 |a Calabresi, P., De Murtas, M., Mercuri, N.B., Bernardi, G., Chronic neuroleptic treatment: D2 dopamine receptor supersensitivity and striatal glutamatergic transmission (1992) Ann. Neurol., 31 (4), pp. 366-373 
504 |a Castro, R., Brito, B., Segovia, J., Martin-Trujillo, J.M., Notario, V., Prenatal haloperidol induces a selective reduction in the expression of plasticity-related genes in neonate rat forebrain (1994) Mol. Brain Res., 26 (12), pp. 74-80 
504 |a Chakos, M.H., Shirakawa, O., Lieberman, J., Lee, H., Bilder, R., Tamminga, C., Striatal enlargement in rats chronically treated with neuroleptics (1998) Biol. Psychiatry, 44 (8), pp. 675-684 
504 |a Coyle, J.T., Campochiaro, P., Ontogenesis of cholinergic-dopaminergic interactions in the rat striatum: A neurochemical study (1976) J. Neurochem., 27, pp. 673-678 
504 |a Creese, I., Burt, D., Snyder, S.H., Dopamine receptor binding predicts clinical and pharmacological potencies of anti-schizophrenic drugs (1976) Science, 192, pp. 481-483 
504 |a Cuomo, V., Perinatal neurotoxicology of psychotropic drugs (1987) Trends Pharmacol. Sci., 8, pp. 346-350 
504 |a Cuomo, V., Cagiano, R., Renna, G., Serinelli, A., Brunello, N., Racagni, G., Comparative evaluation of the behavioral consequences of prenatal and early postnatal exposure to haloperidol in rats (1985) Neurobehav. Toxicol. Teratol., 7 (5), pp. 489-492 
504 |a Dean, J.C., Hailey, H., Moore, S.J., Lloyd, D.J., Turnpenny, P.D., Little, J., Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth (2002) J. Med. Genet., 39 (4), pp. 251-259 
504 |a Dewey, S.L., Smith, G.S., Logan, J., Brodie, J.D., Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects (1993) Proc. Natl. Acad. Sci. U. S. A., 90, pp. 11816-11820 
504 |a Eastwood, S.L., Hefferman, J., Harrison, P.J., Chronic haloperidol treatment differentially affects the expression of synaptic and neuronal plasticity-associated genes (1997) Mol. Psychiatry, 2 (4), pp. 322-329 
504 |a Faustman, E.M., Oinenn, G.S., Risk assessment (2001) Casarett and Doull's Toxicology, the Basic Science of Poisons Sixth Edition, pp. 93-94. , C.D. Klassen. New York: McGraw-Hill 
504 |a Fox, C.A., Mansour, A., Watson Jr., S.J., The effects of haloperidol on dopamine receptor gene expression (1994) Exp. Neurol., 130 (2), pp. 288-303 
504 |a Freed, C.R., Yamamoto, B.K., Regional brain dopamine metabolism: A marker for speed, direction, and posture of moving animals (1985) Science, 229, pp. 62-65 
504 |a Galili, R., Mosberg, Gil-Ad, I., Weizman, A., Melamed, E., Offen, D., Haloperidol-induced neurotoxicity. Possible implications for tardive dyskinesia (2000) J. Neural Transm., 107 (4), pp. 479-490 
504 |a Gjere, N.A., Psychopharmacology in pregnancy (2001) J. Perinat. Neonatal Nurs., 14 (4), pp. 12-35 
504 |a Heyman, G.M., Beer, B., A new approach for evaluating the behavioral effects of antipsychotic drugs (1987) TIPS, 8, pp. 388-393 
504 |a Hill, H.F., Engblom, J., Effects of pre- and postnatal haloperidol administration to pregnant and nursing rats on brain catecholamine levels in their offspring (1984) Dev. Pharmacol. Ther., 7, pp. 188-197 
504 |a Ibarra, G.R., Paratcha, G.C., Wolansky, M.J., Azcurra, J.M., Co-alteration of dopamine D2 receptor and muscarinic acetylcholine receptor binding in rat striatum after circling training (1996) NeuroReport, 7 (1517), pp. 2491-2494 
504 |a Imperato, A., Obiunu, M.C., Gessa, G.L., Is in vivo acetylcholine output under a tonic inhibitory control by dopamine? (1995) J. Neural Transm., Suppl., 45, pp. 91-102 
504 |a Iñiguez, C., Calle, F., Marshall, E., Carreres, J., Morphological effects of chronic haloperidol administration on the postnatal development of the rat striatum (1987) Brain Res., 432 (1), pp. 27-34 
504 |a Lee, M.H., Rabe, A., Neocortical transplant in the micrencephalic rat brain: Morphology and behavior (1988) Brain Res. Bull., 21 (5), pp. 813-824 
504 |a Lescaudron, L., Stein, D.G., Functional recovery following transplants of embryonic brain tissue in rats with lesions of visual, frontal and motor cortex: Problems and prospects for future research (1990) Neuropsychologia, 28 (6), pp. 585-599 
504 |a Levant, B., Grigoriadis, D.E., De Souza, E.B., Relative affinities of dopaminergic drugs at dopamine D2 and D3 receptors (1995) Eur. J. Pharmacol., 278 (3), pp. 243-247 
504 |a Lowry, O.H., Rosebrough, N.J., Lewis Farr, A., Randall, R.J., Protein measurement with Folin phenol reagent (1951) J. Biol. Chem., 158, pp. 265-275 
504 |a Marchand, R., Lajoie, L., Histogenesis of the striatopallidal system in the rat: Neurogenesis on its neurons (1986) Neuroscience, 17 (3), pp. 573-590 
504 |a Middaugh, L.D., Zemp, J.W., Dopaminergic mediation of long-term behavioral effects of in utero drug exposure (1985) Neurobehav. Toxicol. Teratol., 7, pp. 685-689 
504 |a Mihaly, G.W., Morgan, D.J., Placental drug transfer: Effects of gestational age and species (1983) Pharmacol. Ther., 23 (2), pp. 253-266 
504 |a Miller, J.C., Friedhoff, A.J., Prenatal neurotransmitter programming of postnatal receptor function (1988) Prog. Brain Res., 73, pp. 491-508 
504 |a Mitchell, I.J., Cooper, A.C., Griffiths, M.R., Cooper, A.J., Acute administration of haloperidol induces apoptosis of neurons in the striatum and substantia nigra in the rat (2002) Neuroscience, 109 (1), pp. 89-99 
504 |a Nelson, B.K., Evidence for behavioral teratogens in humans (1991) J. Appl. Toxicol., 11 (1), pp. 33-37 
504 |a Rodier, P., Chronology of neuron development: Animal studies and their clinical implications (1980) Dev. Med. Child Neurol., 22 (4), pp. 525-545 
504 |a Rogue, P., Hanauer, A., Zwiller, J., Malaviya, A.N., Vincendon, G., Up-regulation of dopamine D2 receptor mRNA in rat striatum by chronic neuroleptic treatment (1991) Eur. J. Pharmacol., 207 (2), pp. 165-168 
504 |a Rosengarten, H., Friedhoff, A.J., Enduring changes in dopamine receptor cells of pups from drug administration to pregnant and nursing rats (1979) Science, 203, pp. 1133-1135 
504 |a Russi, G., Girotti, P., Cadoni, P., Di Chiara, G., Consolo, S., Neuroleptics increase striatal acetylcholine release by a sequential D1 and D2 receptor mechanism (1993) NeuroReport, 4, pp. 1335-1338 
504 |a Saleh, M.I., Kostrzewa, R.M., MIF-1 attenuates spiroperidol alteration of striatal dopamine D2 receptor ontogeny (1989) Peptides, 10 (1), pp. 35-39 
504 |a Shimohira, M., Iwakawa, Y., Kohyama, J., Rapid-eye-movement sleep in jittery infants (2002) Early Hum. Dev., 66 (1), pp. 25-31 
504 |a Singh, K.P., Singh, M., Effect of prenatal haloperidol exposure on behavioral alteration in rats (2002) Neurotoxicol. Teratol., 24 (4), pp. 497-502 
504 |a Soiza-Reilly, M., Fossati, M., Ibarra, G.R., Azcurra, J.M., Different dopamine D1 and D2 receptors expression after motor activity in the striatal critical period (2004) Brain Res., 1004 (12), pp. 217-221 
504 |a Spear, L.P., The adolescent brain and age-related behavioral manifestations (2000) Neurosci. Biobehav. Rev., 24, pp. 417-463 
504 |a Spear, L.P., File, S.E., Methodological considerations in neurobehavioral teratology (1996) Pharmacol. Biochem. Behav., 55 (4), pp. 455-477 
504 |a Spear, L.P., Scalzo, F.M., Behavioral, psychopharmacological and neurochemical effects of chronic neuroleptic treatment during development (1986) Handbook of Behavioral Teratology, pp. 173-184. , E.P. Riley, & C.V. Vorhees. New York: Plenum. Chapter 8 
504 |a Spigset, O., Haag, S., Excretion of psychotropic drugs into breast milk: Pharmacokinetic overview and therapeutic implications (1998) CNS Drugs, 9, pp. 111-134 
504 |a Srivastava, L.K., Morency, M.A., Mishra, R.K., Ontogeny of dopamine D2 receptor mRNA in rat brain (1992) Eur. J. Pharmacol., 225 (2), pp. 143-150 
504 |a Streissguth, A.P., Treder, R.P., Barr, H.M., Shepard, T.H., Bleyer, W.A., Aspirin and acetaminophen use by pregnant women and subsequent child IQ and attention decrements (1987) Teratology, 35 (2), pp. 211-219 
504 |a Swaab, D.F., Mirmiran, M., The influence of chemicals and environment on brain development: "behavioral teratology" (1985) Prog. Clin. Biol. Res., 163, pp. 447-451 
504 |a Tang, K.-C., Low, M.J., Grandy, D.K., Lovinger, D.M., Dopamine-dependent synaptic plasticity in striatum during in vivo development (2001) Proc. Natl. Acad. Sci. U. S. A., 98 (3), pp. 1255-1260 
504 |a Teischer, M.H., Andersen, S.L., Hostetter Jr., J.C., Evidence for dopamine receptor pruning between adolescence and adulthood in striatum but not nucleus accumbens (1995) Dev. Brain Res., 89 (2), pp. 167-172 
504 |a Thomas, J.D., Fleming, S.L., Riley, E.P., Administration of low doses of MK-801 during ethanol withdrawal in the developing rat pup attenuates alcohol's teratogenic effects (2002) Alcohol., Clin. Exp. Res., 26 (8), pp. 1307-1313 
504 |a Tilson, H.A., The concern for developmental neurotoxicology: Is it justified and what is being done about it? (1995) Environ. Health Perspect., 103 (SUPPL. 6), pp. 147-151 
504 |a Van Vulpen, E.H., Van Der Kooy, D., Striatal cholinergic interneurons: Birthdates predict compartmental localization (1998) Dev. Brain Res., 109 (1), pp. 51-58 
504 |a Vorhees, C.V., Developmental neurotoxicity induced by therapeutic and illicit drugs (1994) Environ. Health Perspect., 102 (SUPPL. 2), pp. 145-153 
504 |a Vorhees, C.V., Molinow, E., Behavioral teratogenesis: Long-term influences on behavior from early exposure to environmental agents (1987) Handbook of Infants Development Second Edition, pp. 913-971. , J.D. Osofsky. New York: Wiley 
504 |a Watanabe, T., Matsuhashi, K., Takayama, S., Placental and blood-brain barrier transfer following prenatal and postnatal exposures to neuroactive drugs: Relationship with partition coefficient and behavioral teratogenesis (1990) Toxicol. Appl. Pharmacol., 105 (1), pp. 66-77 
504 |a Williams, R., Ali, S.F., Scalzo, F.M., Soliman, K., Holson, R.R., Prenatal haloperidol exposure: Effects on brain weights and caudate neurotransmitter levels in rats (1992) Brain Res. Bull., 29 (34), pp. 449-458 
504 |a Wolansky, M.J., Mongiat, L., Ibarra, G.R., Paratcha, G.C., Cabrera, R.J., Azcurra, J.M., Reduction of sample size per experimental group and time per agent examined in a sensitive rat model for behavioral teratology screening routines (1999) Third World Congress on Alternatives and Animal Use in the Life Sciences, Bologna, Italy, 29th August-2nd September, 1999 Alternatives to Laboratory Animals (ATLA) (Suppl.), pp. 165A 
504 |a Xu, S.X., Monsma, F.J., Sibley, D.R., Creese, I., Regulation of D1A and D2 dopamine receptor mRNA during ontogenesis, lesion and chronic antagonist treatment (1992) Life Sci., 50 (5), pp. 383-396 
504 |a Yanai, J., Abu-Roumi, M., Silverman, W.F., Steingart, R.A., Neural grafting as a tool for the study and reversal of neurobehavioral birth defects (1996) Pharmacol. Biochem. Behav., 55 (4), pp. 673-681 
504 |a Yoshida, K., Smith, B., Craggs, M., Kumar, R., Neuroleptic drugs in breast-milk: A study of pharmacokinetics and of possible adverse effects in breast-fed infants (1998) Psychol. Med., 28 (1), pp. 81-91 
520 3 |a Up to 35% of pregnant women take psychotropic drugs at least once during gestation [Austin and Mitchell, 1998]. From concurrent animal and human evidence, it has been proposed that exposure to several psychoactive medications in utero or during lactation increases the risk for permanent brain disorders. Present preventive or therapy practices applied on humans for this type of long-lasting behavioral alterations are mainly based on empirical results. Here, we test an experimental approach designed to counteract a circling performance deficit that appears in Sprague-Dawley rats at puberty on exposure to the dopaminergic blocker haloperidol (HAL) during gestation [J.L. Brusés, J.M. Azcurra, The circling training: A behavioral paradigm for functional teratology testing, in: P.M. Conn (Ed.), Paradigms for the study of behavior, Acad. Press, New York, 1993, pp. 166-179. Method Neurosci. 14]. Gestational exposure to HAL (GD 5-18, 2.5 mg/kg/day ip) induced the expected circling activity decrease in the offspring at the fifth week of life. When prenatal exposure to HAL was continued through lactation (PD5-21, 1.5 mg/kg/day ip), rats otherwise showed a control-like circling performance. No difference was yet found between lactation-only, HAL-exposed pups and saline (SAL)-treated controls (n=8 each group). We further performed saturating (3H)-spiroperidol (SPI) binding assays on striatal P2 membrane fractions 2 months later. The dopamine-type D2-specific binding results suggested that above circling behavior findings could be partially explained by enduring HAL-induced neurochemical changes. The role of critical periods of sensitivity as transient windows for opportunistic therapies for behavioral teratology is discussed. © 2004 Elsevier Inc. All rights reserved.  |l eng 
536 |a Detalles de la financiación: Umweltbundesamt 
536 |a Detalles de la financiación: Universidad Nacional del Centro de la Provincia de Buenos Aires 
536 |a Detalles de la financiación: Consejo Nacional de Investigaciones Científicas y Técnicas 
536 |a Detalles de la financiación: Consejo Nacional de Investigaciones Científicas y Técnicas 
536 |a Detalles de la financiación: This work was supported with grants from Universidad Nacional de Buenos Aires (UBA) and Consejo Nacional de Investigaciones Cientı́ficas y Técnicas (CONICET), Argentina. MJW gratefully acknowledges UBA for the granting of a fellowship. We are especially grateful to Gustavo Paratcha. We also thank the efforts of Beatriz Gonzalez and Javier Calcagno (Biometry, School of Sciences, UBA). The authors would like to express our appreciation to Mr. Stein, from Janssen Laboratories (Buenos Aires), for fulfilling our request for haloperidol, and Robert Macphail and Kevin Crofton for their kind help in revising the original version of the manuscript. 
593 |a Interdisc. Proj. on Neuroteratology, Depto. de Biodiversidad Y Biol. Exp., Universidad de Buenos Aires, C1428EHA Buenos Aires, Argentina 
593 |a C. F. Melo 4127 (C.P. 1602), Buenos Aires, Argentina 
593 |a Neurotoxicology Division, Natl. Hlth. Environ. Effects Res. L., US EPA, Research Triangle Park, NC 27711, United States 
690 1 0 |a BEHAVIORAL TERATOGEN 
690 1 0 |a HALOPERIDOL 
690 1 0 |a THERAPEUTIC AGENT 
690 1 0 |a HALOPERIDOL 
690 1 0 |a ANIMAL EXPERIMENT 
690 1 0 |a ANIMAL MODEL 
690 1 0 |a ANIMAL TISSUE 
690 1 0 |a ARTICLE 
690 1 0 |a BEHAVIOR DISORDER 
690 1 0 |a BEHAVIOR TERATOLOGY 
690 1 0 |a CIRCLING BEHAVIOR 
690 1 0 |a CONTROLLED STUDY 
690 1 0 |a FEMALE 
690 1 0 |a LACTATION 
690 1 0 |a NONHUMAN 
690 1 0 |a PERINATAL DRUG EXPOSURE 
690 1 0 |a PRENATAL DRUG EXPOSURE 
690 1 0 |a PRIORITY JOURNAL 
690 1 0 |a PROGENY 
690 1 0 |a ANALYSIS OF VARIANCE 
690 1 0 |a ANIMALS 
690 1 0 |a ANIMALS, NEWBORN 
690 1 0 |a BEHAVIOR, ANIMAL 
690 1 0 |a BRAIN 
690 1 0 |a DOPAMINE ANTAGONISTS 
690 1 0 |a FEMALE 
690 1 0 |a HALOPERIDOL 
690 1 0 |a MALE 
690 1 0 |a PREGNANCY 
690 1 0 |a PRENATAL EXPOSURE DELAYED EFFECTS 
690 1 0 |a RADIOLIGAND ASSAY 
690 1 0 |a RANDOM ALLOCATION 
690 1 0 |a RATS 
690 1 0 |a RATS, SPRAGUE-DAWLEY 
690 1 0 |a SPIPERONE 
690 1 0 |a STEREOTYPED BEHAVIOR 
690 1 0 |a STEREOTYPIC MOVEMENT DISORDER 
690 1 0 |a TRITIUM 
690 1 0 |a ANIMALIA 
700 1 |a Soiza-Reilly, M. 
700 1 |a Fossati, M. 
700 1 |a Azcurra, J.M. 
773 0 |d 2004  |g v. 26  |h pp. 561-569  |k n. 4  |p Neurotoxicol. Teratol.  |x 08920362  |t Neurotoxicology and Teratology 
856 4 1 |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-2942625682&doi=10.1016%2fj.ntt.2004.04.006&partnerID=40&md5=32d0f899c67b14f9f3fc4c7fa0dd85b6  |y Registro en Scopus 
856 4 0 |u https://doi.org/10.1016/j.ntt.2004.04.006  |y DOI 
856 4 0 |u https://hdl.handle.net/20.500.12110/paper_08920362_v26_n4_p561_Wolansky  |y Handle 
856 4 0 |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_08920362_v26_n4_p561_Wolansky  |y Registro en la Biblioteca Digital 
961 |a paper_08920362_v26_n4_p561_Wolansky  |b paper  |c PE 
962 |a info:eu-repo/semantics/article  |a info:ar-repo/semantics/artículo  |b info:eu-repo/semantics/publishedVersion 
999 |c 82170